Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 47.50
-0.55 (-1.14%)
Jun 18, 2026, 5:35 PM CET
Dermapharm Holding SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 144.21 | 132.41 | 113.79 | 62.37 | 134.24 | 209.58 |
Depreciation & Amortization | 35.81 | 35.45 | 34.93 | 33.38 | 23.7 | 20.66 |
Other Amortization | 44.82 | 44.82 | 43.53 | 52.57 | 27.73 | 24.59 |
Loss (Gain) From Sale of Assets | 0.15 | 1.17 | 2.72 | -2.57 | -0.2 | -0.4 |
Asset Writedown & Restructuring Costs | 11.74 | 11.74 | 8.32 | 15.82 | 43.48 | 9.91 |
Loss (Gain) on Equity Investments | -4.08 | -4.34 | -1.52 | 7.16 | 13.54 | -0.32 |
Other Operating Activities | 18.87 | 1.58 | 17.67 | 41.65 | 50.18 | 32.62 |
Change in Other Net Operating Assets | 33.23 | 6.32 | -18.06 | 9.04 | -4.14 | -46.27 |
Operating Cash Flow | 284.74 | 229.15 | 201.38 | 219.42 | 288.53 | 250.37 |
Operating Cash Flow Growth | 65.05% | 13.79% | -8.22% | -23.95% | 15.24% | 90.98% |
Capital Expenditures | -43.89 | -42.12 | -38.24 | -41.54 | -39.01 | -61.2 |
Sale of Property, Plant & Equipment | 0.61 | 0.8 | 3.79 | 2.82 | 0.68 | 2.52 |
Cash Acquisitions | -48.96 | -51.24 | - | -389.4 | -69.79 | -22.51 |
Investment in Securities | -9.82 | -9.82 | 0.3 | 7.95 | 3.93 | -48.25 |
Other Investing Activities | 4 | 4.13 | 4.53 | 4.74 | 5.18 | 0.1 |
Investing Cash Flow | -98.06 | -98.24 | -29.61 | -415.43 | -99.01 | -129.35 |
Long-Term Debt Issued | - | 170 | 111.17 | 715 | 469.95 | 10 |
Long-Term Debt Repaid | - | -108.22 | -219.3 | -420.86 | -541.19 | -35.91 |
Net Debt Issued (Repaid) | 32.71 | 61.78 | -108.13 | 294.14 | -71.24 | -25.91 |
Common Dividends Paid | -48.46 | -48.46 | -47.38 | -56.53 | -116.83 | -47.38 |
Other Financing Activities | -58.96 | -59.43 | -53.66 | -33.07 | -11.69 | -7.69 |
Financing Cash Flow | -74.7 | -46.11 | -209.17 | 204.54 | -199.77 | -80.98 |
Foreign Exchange Rate Adjustments | -1.24 | -2.69 | -0.04 | -0 | -0.15 | 1.07 |
Miscellaneous Cash Flow Adjustments | 0 | - | 0 | -0.83 | - | 0 |
Net Cash Flow | 110.74 | 82.12 | -37.44 | 7.7 | -10.4 | 41.11 |
Free Cash Flow | 240.85 | 187.03 | 163.14 | 177.88 | 249.52 | 189.17 |
Free Cash Flow Growth | 83.50% | 14.64% | -8.29% | -28.71% | 31.91% | 109.48% |
Free Cash Flow Margin | 20.37% | 15.87% | 13.65% | 15.46% | 23.98% | 19.70% |
Free Cash Flow Per Share | 4.47 | 3.47 | 3.03 | 3.30 | 4.63 | 3.51 |
Cash Interest Paid | 51.3 | 51.77 | 53.65 | 33.07 | 7.76 | 7.69 |
Cash Income Tax Paid | 64.75 | 89.89 | 83.84 | 65.37 | 40.59 | 44.85 |
Levered Free Cash Flow | 160.29 | 100.96 | 99.52 | 106.43 | 218.88 | 127.86 |
Unlevered Free Cash Flow | 189.34 | 131.38 | 136.03 | 140.78 | 226.59 | 133.38 |
Change in Working Capital | 33.23 | 6.32 | -18.06 | 9.04 | -4.14 | -46.27 |